Evidence map›Paper›PMID 36945445›Full record

ArticlebioRxiv : the preprint server for biology2024

Generally-healthy individuals with aberrant bowel movement frequencies show enrichment for microbially-derived blood metabolites associated with reduced kidney function.

Johannes P Johnson-Martínez, Christian Diener, Anne E Levine, Tomasz Wilmanski, David L Suskind, Alexandra Ralevski, Jennifer Hadlock, Andrew T Magis, Leroy Hood, Noa Rappaport and 1 more

Open access · greenFull text readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 8 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Johannes P Johnson-MartínezInstitute for Systems Biology, Seattle, WA 98109, USA.ORCID 0000-0002-8568-0791
Christian DienerInstitute for Systems Biology, Seattle, WA 98109, USA.ORCID 0000-0002-7476-0868
Anne E LevineInstitute for Systems Biology, Seattle, WA 98109, USA.
Tomasz WilmanskiInstitute for Systems Biology, Seattle, WA 98109, USA.ORCID 0000-0003-1059-073X
David L SuskindSeattle Children's Hospital, Seattle, WA 98105, USA.ORCID 0000-0002-3524-5150
Alexandra RalevskiInstitute for Systems Biology, Seattle, WA 98109, USA.
Jennifer HadlockInstitute for Systems Biology, Seattle, WA 98109, USA.ORCID 0000-0001-6103-7606
Andrew T MagisInstitute for Systems Biology, Seattle, WA 98109, USA.ORCID 0000-0003-0576-677X
Leroy HoodInstitute for Systems Biology, Seattle, WA 98109, USA.ORCID 0000-0001-7158-3678
Noa RappaportInstitute for Systems Biology, Seattle, WA 98109, USA.
Sean M GibbonsInstitute for Systems Biology, Seattle, WA 98109, USA.ORCID 0000-0002-8724-7916
Institute for Systems Biology · USUniversity of Washington · USSeattle Children's Hospital · US

Funding

CyberGut: towards personalized human-microbiome metabolic modeling for precision health and nutritionR01DK133468 · NIDDK · INSTITUTE FOR SYSTEMS BIOLOGY · PI Sean Michael Gibbons · 2022 to 2026
$3.6M
NIDDK NIH HHS R01 DK133468
6 · The paper itself

Abstract

Bowel movement frequency (BMF) has been linked to changes in the composition of the human gut microbiome and to many chronic conditions, like metabolic disorders, neurodegenerative diseases, chronic kidney disease (CKD), and other intestinal pathologies like irritable bowel syndrome and inflammatory bowel disease. Lower BMF (constipation) can lead to compromised intestinal barrier integrity and a switch from saccharolytic to proteolytic fermentation within the microbiota, giving rise to microbially-derived toxins that may make their way into circulation and cause damage to organ systems. However, the connections between BMF, gut microbial metabolism, and the early-stage development and progression of chronic disease remain underexplored. Here, we examined the phenotypic impact of BMF variation in a cohort of generally-healthy, community dwelling adults with detailed clinical, lifestyle, and multi-omic data. We showed significant differences in microbially-derived blood plasma metabolites, gut bacterial genera, clinical chemistries, and lifestyle factors across BMF groups that have been linked to inflammation, cardiometabolic health, liver function, and CKD severity and progression. We found that the higher plasma levels of 3-indoxyl sulfate (3-IS), a microbially-derived metabolite associated with constipation, was in turn negatively associated with estimated glomerular filtration rate (eGFR), a measure of kidney function. Causal mediation analysis revealed that the effect of BMF on eGFR was significantly mediated by 3-IS. Finally, we identify self-reported diet, lifestyle, and psychological factors associated with BMF variation, which indicate several common-sense strategies for mitigating constipation and diarrhea. Overall, we suggest that aberrant BMF is an underappreciated risk factor in the development of chronic diseases, even in otherwise healthy populations.

Identifiers

PMID36945445
PMCPMC10028848
OpenAlexW4323668822

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read33
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.